Rxcurve
HCPCS J1205 · per 500 MG

Chlorothiazide sodium inj

Products billed under this code include Chlorothiazide Sodium.

Payment limit per 500 MG, by effective quarter, 1Q21 to 4Q26. Gaps mean the code was not in that quarter’s file, or CMS gave no payment limit.

Products billed under J1205

From the 4Q26 NDC–HCPCS crosswalk. “Limit / pkg” is the 4Q26 payment limit times the billing units in one package.

ProductLabelerNDCUnits / pkgLimit / pkg
Chlorothiazide Sodium American Regent, Inc. 00517-1820-01 1 $63.398
Chlorothiazide Sodium Sagent Pharmaceuticals 25021-0305-20 1 $63.398
Chlorothiazide Sodium Sagent Pharmaceuticals 25021-0305-66 1 $63.398
Chlorothiazide Sodium Sun Pharmaceutical Global FZE. 47335-0330-40 1 $63.398
Chlorothiazide Sodium FreseniUS Kabi USA, LLC 63323-0658-20 1 $63.398
Chlorothiazide Sodium FreseniUS Kabi USA, LLC 63323-0658-27 1 $63.398
Chlorothiazide Sodium FreseniUS Kabi USA, LLC 63323-0658-94 1 $63.398

Every quarter

QuarterPayment limitChangeBilling unitDescriptionSource file
4Q26 $63.398 −$14.373 500 MG Chlorothiazide sodium inj v1, posted September 17, 2026
3Q26 $77.771 +$30.85 500 MG Chlorothiazide sodium inj v1, posted September 15, 2026
2Q26 $46.921 −$11.205 500 MG Chlorothiazide sodium inj v1, posted September 15, 2026
1Q26 $58.126 +$18.679 500 MG Chlorothiazide sodium inj v1, posted September 15, 2026
4Q25 $39.447 −$0.935 500 MG Chlorothiazide sodium inj v1, posted September 8, 2026
3Q25 $40.382 +$7.90 500 MG Chlorothiazide sodium inj v1, posted March 10, 2026
2Q25 $32.482 −$27.982 500 MG Chlorothiazide sodium inj v1, posted March 10, 2026
1Q25 $60.464 +$20.567 500 MG Chlorothiazide sodium inj v1, posted December 19, 2025
4Q24 $39.897 −$23.892 500 MG Chlorothiazide sodium inj v1, posted June 11, 2025
3Q24 $63.789 −$23.966 500 MG Chlorothiazide sodium inj v1, posted June 11, 2025
2Q24 $87.755 −$33.591 500 MG Chlorothiazide sodium inj v1, posted March 11, 2025
1Q24 $121.346 +$44.613 500 MG Chlorothiazide sodium inj v1, posted December 19, 2024
4Q23 $76.733 +$15.166 500 MG Chlorothiazide sodium inj v1, posted October 10, 2024
3Q23 $61.567 −$15.305 500 MG Chlorothiazide sodium inj v1, posted June 5, 2024
2Q23 $76.872 +$36.358 500 MG Chlorothiazide sodium inj v1, posted February 23, 2024
1Q23 $40.514 −$33.904 500 MG Chlorothiazide sodium inj v1, posted December 6, 2023
4Q22 $74.418 +$43.868 500 MG Chlorothiazide sodium inj v1, posted June 22, 2023
3Q22 $30.55 −$11.755 500 MG Chlorothiazide sodium inj v1, posted June 9, 2023
2Q22 $42.305 −$1.601 500 MG Chlorothiazide sodium inj v1, posted December 14, 2022
1Q22 $43.906 −$12.232 500 MG Chlorothiazide sodium inj v1, posted June 8, 2022
4Q21 $56.138 −$11.199 500 MG Chlorothiazide sodium inj v1, posted June 2, 2022
3Q21 $67.337 +$1.641 500 MG Chlorothiazide sodium inj v1, posted June 2, 2022
2Q21 $65.696 +$13.262 500 MG Chlorothiazide sodium inj v1, posted March 1, 2022
1Q21 $52.434 – 500 MG Chlorothiazide sodium inj v1, posted December 10, 2021

“Change” is the difference from the previous quarter, shown only when both quarters have a payment limit and the billing unit is the same. “vs. last quarter” and “vs. a year ago” follow the same rule.

CMS source files